American Portfolios Advisors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

American Portfolios Advisors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-144	Closed	-$576	–	2973
2019 Q4	$576	Hold	144	–	–	﹤0.01%	2736
2019 Q3	$706	Hold	144	–	–	﹤0.01%	2684
2019 Q2	$877	Hold	144	–	–	﹤0.01%	2601
2019 Q1	$837	Hold	144	–	–	﹤0.01%	2494
2018 Q4	$1.94K	Buy	144 +30	+26%	+$506	﹤0.01%	2145
2018 Q3	$2.21K	Hold	114	–	–	﹤0.01%	2219
2018 Q2	$2.91K	Hold	114	–	–	﹤0.01%	2129
2018 Q1	$2.3K	Hold	114	–	–	﹤0.01%	2077
2017 Q4	$2.29K	Buy	+114	New	+$2.24K	﹤0.01%	2027

Other funds holding DPLO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

American Portfolios Advisors's DPLO Position: Q1 2020 in Review

American Portfolios Advisors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 144 shares — an estimated $576 sold.

American Portfolios Advisors first reported a position in DPLO in Q4 2017 and held it in 9 quarters. The position peaked at $2.91K in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

American Portfolios Advisors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
American Portfolios Advisors sold 144 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $576.
American Portfolios Advisors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2017 and held it in 9 quarters.
American Portfolios Advisors's DIPLOMAT PHARMACY, INC. position peaked at $2.91K in Q2 2018.
1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on American Portfolios Advisors's 13F filing for Q1 2020, filed 24 Mar 2023.